Table6_Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies.XLSX
The cardiac sodium–calcium exchanger (NCX1) is important for normal Na+- and Ca2+-homeostasis and cardiomyocyte relaxation and contraction. It has been suggested that NCX1 activity is reduced by phosphorylated phospholemman (pSer68-PLM); however its direct interaction with PLM is debated. Disruption of the potentially inhibitory pSer68-PLM-NCX1 interaction might be a therapeutic strategy to increase NCX1 activity in cardiac disease. In the present study, we aimed to analyze the binding affinities and kinetics of the PLM-NCX1 and pSer68-PLM-NCX1 interactions by surface plasmon resonance (SPR) and to develop a proteolytically stable NCX1 activator peptide for future in vivo studies. The cytoplasmic parts of PLM (PLMcyt) and pSer68-PLM (pSer68-PLMcyt) were found to bind strongly to the intracellular loop of NCX1 (NCX1cyt) with similar KD values of 4.1 ± 1.0 nM and 4.3 ± 1.9 nM, but the PLMcyt-NCX1cyt interaction showed higher on/off rates. To develop a proteolytically stable NCX1 activator, we took advantage of a previously designed, high-affinity PLM binding peptide (OPT) that was derived from the PLM binding region in NCX1 and that reverses the inhibitory PLM (S68D)-NCX1 interaction in HEK293. We performed N- and C-terminal truncations of OPT and identified PYKEIEQLIELANYQV as the minimum sequence required for pSer68-PLM binding. To increase peptide stability in human serum, we replaced the proline with an N-methyl-proline (NOPT) after identification of N-terminus as substitution tolerant by two-dimensional peptide array analysis. Mass spectrometry analysis revealed that the half-life of NOPT was increased 17-fold from that of OPT. NOPT pulled down endogenous PLM from rat left ventricle lysate and exhibited direct pSer68-PLM binding in an ELISA-based assay and bound to pSer68-PLMcyt with a KD of 129 nM. Excess NOPT also reduced the PLMcyt-NCX1cyt interaction in an ELISA-based competition assay, but in line with that NCX1 and PLM form oligomers, NOPT was not able to outcompete the physical interaction between endogenous full length proteins. Importantly, cell-permeable NOPT-TAT increased NCX1 activity in cardiomyocytes isolated from both SHAM-operated and aorta banded heart failure (HF) mice, indicating that NOPT disrupted the inhibitory pSer68-PLM-NCX1 interaction. In conclusion, we have developed a proteolytically stable NCX1-derived PLM binding peptide that upregulates NCX1 activity in SHAM and HF cardiomyocytes.
History
References
- https://doi.org//10.1161/circresaha.116.309202
- https://doi.org//10.1074/jbc.m414703200
- https://doi.org//10.1161/hypertensionaha.120.14704
- https://doi.org//10.1016/j.ceca.2011.02.006
- https://doi.org//10.1110/ps.051899406
- https://doi.org//10.1152/physrev.1999.79.3.763
- https://doi.org//10.1161/01.res.0000181172.27931.c3
- https://doi.org//10.1074/jbc.m606254200
- https://doi.org//10.1074/jbc.m603223200
- https://doi.org//10.1021/ar8000603
- https://doi.org//10.1007/978-1-4614-4756-6_15
- https://doi.org//10.1038/nbt.1511
- https://doi.org//10.1016/s0006-3495(03)75140-6
- https://doi.org//10.1111/j.1469-7793.1997.003bo.x
- https://doi.org//10.1007/s00726-020-02890-9
- https://doi.org//10.1161/circresaha.119.315891
- https://doi.org//10.1016/s0040-4020(01)85612-x
- https://doi.org//10.1016/s0022-1759(02)00137-0
- https://doi.org//10.1152/ajpcell.00523.2008
- https://doi.org//10.1016/j.yjmcc.2005.09.005
- https://doi.org//10.1016/j.celrep.2020.107697
- https://doi.org//10.1016/j.molcel.2006.09.006
- https://doi.org//10.1074/jbc.m115.677898
- https://doi.org//10.1161/01.cir.99.5.641
- https://doi.org//10.1152/ajpcell.2000.278.4.c661
- https://doi.org//10.1074/jbc.271.23.13609
- https://doi.org//10.1074/jbc.270.15.8996
- https://doi.org//10.1073/pnas.1016114108
- https://doi.org//10.1016/j.bmc.2017.06.052
- https://doi.org//10.1152/ajpcell.00452.2005
- https://doi.org//10.1529/biophysj.105.072447
- https://doi.org//10.1161/01.res.0000151334.48676.68
- https://doi.org//10.1085/jgp.109.2.273
- https://doi.org//10.1093/cvr/cvy141
- https://doi.org//10.1152/ajpheart.01062.2001
- https://doi.org//10.1007/978-1-4614-4756-6_18
- https://doi.org//10.1016/j.ceca.2020.102190
- https://doi.org//10.1093/nar/gky1106
- https://doi.org//10.1016/j.nbd.2011.10.007
- https://doi.org//10.1021/bi800177t
- https://doi.org//10.1111/j.1469-7793.2000.00599.x
- https://doi.org//10.1113/jphysiol.2014.282319
- https://doi.org//10.1017/erm.2012.10
- https://doi.org//10.1074/jbc.m110.198036
- https://doi.org//10.1016/s1470-2045(14)70379-1
- https://doi.org//10.1093/cvr/cvw113
- https://doi.org//10.1042/bj3040635
- https://doi.org//10.1152/ajpheart.00861.2013
- https://doi.org//10.1074/jbc.m114.602581
- https://doi.org//10.1042/bcj20160465
- https://doi.org//10.1152/ajpcell.00196.2010
- https://doi.org//10.1161/01.res.0000069701.19660.14
- https://doi.org//10.1085/jgp.202012633
- https://doi.org//10.1016/j.jconrel.2019.02.016
- https://doi.org//10.1074/jbc.m512092200
- https://doi.org//10.1152/japplphysiol.00583.2002
- https://doi.org//10.1152/ajpcell.00069.2011